Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia

Diabetologia

Volumn 40, Issue 11, 1997, Pages 1269-1277

  Sainsbury, A ^a,b   Rohner Jeanrenaud, F ^a   Cusin, I ^a   Zakrzewska, K E ^a   Halban, P A ^a   Gaillard, R C ^c   Jeanrenaud, B ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

glucose utilisation; hypothalamo pituitary adrenal axis; insulin; Intracerebroventricular; neuropeptide Y; proinsulin; vagus nerve

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GLUCOSE; INSULIN; NEUROPEPTIDE Y; PROINSULIN;

ADIPOSE TISSUE; ADOLESCENT; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; FEMALE; GLUCOSE UTILIZATION; HYPERINSULINEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MUSCLE METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; VAGUS NERVE;

ADIPOSE TISSUE; ADRENOCORTICOTROPIC HORMONE; ANIMALS; BODY WEIGHT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; EATING; FEMALE; GLUCOSE; HYPOTHALAMUS; INJECTIONS, INTRAVENTRICULAR; INSULIN; MUSCLE, SKELETAL; NEUROPEPTIDE Y; ORGAN SIZE; PANCREAS; PITUITARY-ADRENAL SYSTEM; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VAGOTOMY; VAGUS NERVE;

EID: 0030831040     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s001250050820     Document Type: Article

References (45)

1. 1. SHC Hendry 1993 Organization of neuropeptide Y neurons in the mammalian central nervous system WF Colmers C Wahlestedt The biology of neuropeptide Y and related peptides Humana Press Inc New Jersey 65 156 Hendry SHC (1993) Organization of neuropeptide Y neurons in the mammalian central nervous system. In: Colmers WF, Wahlestedt C (eds) The biology of neuropeptide Y and related peptides. Humana Press Inc, New Jersey, pp 65–156
2. 2. E Ergene JC Dunbar RA Barraco 1993 Visceroendocrine responses elicited by neuropeptide Y in the nucleus tractus solitarius Brain Res Bull 32 461 465 8221137 10.1016/0361-9230(93)90291-I 1:CAS:528:DyaK2cXht1Gjsbc%3D Ergene E, Dunbar JC, Barraco RA (1993) Visceroendocrine responses elicited by neuropeptide Y in the nucleus tractus solitarius. Brain Res Bull 32: 461–465
3. 3. JK McDonald JI Koenig 1993 Neuropeptide Y actions on reproductive and endocrine functions WF Colmers C Wahlestadt The biology of neuropeptide Y and related peptides Humana Press Inc New Jersey 419 456 McDonald JK, Koenig JI (1993) Neuropeptide Y actions on reproductive and endocrine functions. In: Colmers WF, Wahlestadt C (eds) The biology of neuropeptide Y and related peptides. Humana Press Inc, New Jersey, pp 419–456
4. 4. BG Stanley 1993 Neuropeptide Y in multiple hypothalamic sites controls eating behavior, endocrine, and autonomic systems for body energy balance WF Colmers Wahlestedt C The biology of neuropeptide Y and related peptides Humana Press Inc New Jersey 457 509 Stanley BG (1993) Neuropeptide Y in multiple hypothalamic sites controls eating behavior, endocrine, and autonomic systems for body energy balance. In: Colmers WF, Wahlestedt C (eds) The biology of neuropeptide Y and related peptides. Humana Press Inc, New Jersey, pp 457–509
5. 5. S Dryden H Frankish Q Wang G Williams 1994 Neuropeptide Y and energy balance: one way ahead for the treatment of obesity? Eur J Clin Invest 24 293 308 7916292 10.1111/j.1365-2362.1994.tb01089.x 1:CAS:528:DyaK2cXksFSitbc%3D Dryden S, Frankish H, Wang Q, Williams G (1994) Neuropeptide Y and energy balance: one way ahead for the treatment of obesity? Eur J Clin Invest 24: 293–308
6. 6. van Huijsduijnen O Bchini-Hooft F Rohner-Jeanrenaud B Jeanrenaud 1993 Hypothalamic neuropeptide Y messenger ribonucleic acid levels in pre-obese and genetically obese (fa/fa) rats; potential regulation thereof by corticotropin-releasing factor J Neuroendocrinol 5 381 386 10.1111/j.1365-2826.1993.tb00498.x Bchini-Hooft van Huijsduijnen O, Rohner-Jeanrenaud F, Jeanrenaud B (1993) Hypothalamic neuropeptide Y messenger ribonucleic acid levels in pre-obese and genetically obese (fa/fa) rats; potential regulation thereof by corticotropin-releasing factor. J Neuroendocrinol 5: 381–386
7. 7. G Williams L Shellard DE Lewis 1992 Hypothalamic neuropeptide Y disturbances in the obese (cp/cp) JCR: LA corpulent rat Peptides 13 537 540 1523165 10.1016/0196-9781(92)90085-H 1:CAS:528:DyaK38Xks1yjsro%3D Williams G, Shellard L, Lewis DE et al. (1992) Hypothalamic neuropeptide Y disturbances in the obese (cp/cp) JCR: LA corpulent rat. Peptides 13: 537–540
8. 8. TW Stephens M Basinski PK Bristow 1995 The role of neuropeptide Y in the antiobesity action of the obese gene product Nature 377 530 532 7566151 10.1038/377530a0 1:CAS:528:DyaK2MXoslWlsbc%3D Stephens TW, Basinski M, Bristow PK et al. (1995) The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377: 530–532
9. 9. BG Stanley SE Kyrkouli S Lampert SF Leibowitz 1986 Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity Peptides 7 1189 1192 3470711 10.1016/0196-9781(86)90149-X 1:CAS:528:DyaL2sXhtFequ7Y%3D Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF (1986) Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 7: 1189–1192
10. 10. CJ Billington JE Briggs S Harker M Grace AS Levine 1994 Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism Am J Physiol 266 R1765 R1770 8024026 1:CAS:528:DyaK2cXlt1KisLs%3D Billington CJ, Briggs JE, Harker S, Grace M, Levine AS (1994) Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am J Physiol 266: R1765-R1770
11. 11. N Zarjevski I Cusin R Vettor F Rohner-Jeanrenaud B Jeanrenaud 1993 Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity Endocrinology 133 1753 1758 8404618 10.1210/en.133.4.1753 1:CAS:528:DyaK2cXhtlyl Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B (1993) Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 133: 1753–1758
12. 12. N Zarjevski I Cusin R Vettor F Rohner-Jeanrenaud B Jeanrenaud 1994 Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle Diabetes 43 764 769 8194661 10.2337/diabetes.43.6.764 1:CAS:528:DyaK2cXkt1Oku7c%3D Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B (1994) Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle. Diabetes 43: 764–769
13. 13. R Vettor N Zarjevski I Cusin F Rohner-Jeanrenaud B Jeanrenaud 1994 Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats Diabetologia 37 1202 1208 7895949 10.1007/BF00399793 1:CAS:528:DyaK2MXjvVKnt7k%3D Vettor R, Zarjevski N, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B (1994) Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia 37: 1202–1208
14. 14. A Sainsbury I Cusin F Rohner-Jeanrenaud B Jeanrenaud 1997 Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats Diabetes 46 209 214 9000696 10.2337/diabetes.46.2.209 1:CAS:528:DyaK2sXmtlyltg%3D%3D Sainsbury A, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B (1997) Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats. Diabetes 46: 209–214
15. 15. C Guillaume-Gentil F Assimacopoulos-Jeannet B Jeanrenaud 1993 Involvement of non-esterified fatty acid oxidation in glucocorticoid-induced peripheral insulin resistance in vivo in rats Diabetologia 36 899 906 8243867 10.1007/BF02374470 1:CAS:528:DyaK2cXhsFCju74%3D Guillaume-Gentil C, Assimacopoulos-Jeannet F, Jeanrenaud B (1993) Involvement of non-esterified fatty acid oxidation in glucocorticoid-induced peripheral insulin resistance in vivo in rats. Diabetologia 36: 899–906
16. 16. I Cusin J Terrettaz F Rohner-Jeanrenaud N Zarjevski F Assimacopoulos-Jeannet B Jeanrenaud 1990 Hyperinsu-linemia increases the amount of GLUT4 mRNA in white adipose tissue and decreases that of muscles: a clue for increased fat depot and insulin resistance Endocrinology 127 3246 3248 2249650 1:CAS:528:DyaK3MXjs1egsg%3D%3D Cusin I, Terrettaz J, Rohner-Jeanrenaud F, Zarjevski N, Assimacopoulos-Jeannet F, Jeanrenaud B (1990) Hyperinsu-linemia increases the amount of GLUT4 mRNA in white adipose tissue and decreases that of muscles: a clue for increased fat depot and insulin resistance. Endocrinology 127: 3246–3248
17. 17. DL Coleman 1988 Classical diabetes models: past lessions and potential new therapies E Shafrir AE Renold Frontiers in diabetes research. Lessons from animal diabetes II John Libbey & Co Ltd London 253 256 Coleman DL (1988) Classical diabetes models: past lessions and potential new therapies. In: Shafrir E, Renold AE (eds) Frontiers in diabetes research. Lessons from animal diabetes II. John Libbey & Co Ltd, London, pp 253–256
18. 18. R Nosadini Prato S Del A Tiengo 1983 Insulin resistance in Cushing’s syndrome J Clin Endocrinol Metab 57 529 536 6348064 1:STN:280:DyaL3s3ms1Snsg%3D%3D Nosadini R, Del Prato S, Tiengo A et al. (1983) Insulin resistance in Cushing’s syndrome. J Clin Endocrinol Metab 57: 529–536
19. 19. C Guillaume-Gentil F Rohner-Jeanrenaud F Abramo GE Bestetti GL Rossi B Jeanrenaud 1990 Abnormal regulation of the hypothalamo-pituitary-adrenal axis in the genetically obese fa/fa rat Endocrinology 126 1873 1879 2318147 1:CAS:528:DyaK3cXitlenu7k%3D Guillaume-Gentil C, Rohner-Jeanrenaud F, Abramo F, Bestetti GE, Rossi GL, Jeanrenaud B (1990) Abnormal regulation of the hypothalamo-pituitary-adrenal axis in the genetically obese fa/fa rat. Endocrinology 126: 1873–1879
20. 20. B Jeanrenaud 1991 Neuroendocrinology and evolutionary aspects of experimental obesity Y Oomura S Tarui S Inoue T Shimazu Progress in obesity research 1990 John Libbey Cornwall 409 421 Jeanrenaud B (1991) Neuroendocrinology and evolutionary aspects of experimental obesity. In: Oomura Y, Tarui S, Inoue S, Shimazu T (eds) Progress in obesity research 1990. John Libbey, Cornwall, pp 409–421
21. 21. A Sainsbury F Rohner-Jeanrenaud E Grouzmann B Jeanrenaud 1996 Acute intracerebroventricular administration of neuropeptide Y stimulates corticosterone output and feeding but not insulin output in normal rats Neuroendocrinology 63 318 326 8739887 10.1159/000126972 1:CAS:528:DyaK28XivVKkur8%3D Sainsbury A, Rohner-Jeanrenaud F, Grouzmann E, Jeanrenaud B (1996) Acute intracerebroventricular administration of neuropeptide Y stimulates corticosterone output and feeding but not insulin output in normal rats. Neuroendocrinology 63: 318–326
22. 22. F Rohner-Jeanrenaud CD Walker R Greco-Perotto B Jeanrenaud 1989 Central corticotropin-releasing factor administration prevents the excessive body weight gain of genetically obese (fa/fa) rats Endocrinology 124 733 739 2536319 1:CAS:528:DyaL1MXhs1Kgtbk%3D 10.1210/endo-124-2-733 Rohner-Jeanrenaud F, Walker CD, Greco-Perotto R, Jeanrenaud B (1989) Central corticotropin-releasing factor administration prevents the excessive body weight gain of genetically obese (fa/fa) rats. Endocrinology 124: 733–739
23. 23. R Hadid E Spinedi T Daneva G Grau RC Gaillard 1995 Repeated endotoxin treatment decreases immune and hypothalamo-pituitary-adrenal axis responses: effects of orchidectomy and testosterone therapy Neuroendocrinology 62 348 355 8544948 10.1159/000127024 1:CAS:528:DyaK2MXovVWjuro%3D Hadid R, Spinedi E, Daneva T, Grau G, Gaillard RC (1995) Repeated endotoxin treatment decreases immune and hypothalamo-pituitary-adrenal axis responses: effects of orchidectomy and testosterone therapy. Neuroendocrinology 62: 348–355
24. 24. E Spinedi M Giacomini MC Jacquier RC Gaillard 1991 Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action Neuroendocrinology 53 160 170 1849620 10.1159/000125713 1:CAS:528:DyaK3MXpsFensQ%3D%3D Spinedi E, Giacomini M, Jacquier MC, Gaillard RC (1991) Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action. Neuroendocrinology 53: 160–170
25. 25. B Schnetzler G Murakawa D Abalos P Halban R Seiden 1993 Adapatation to supraphysiologic levels of insulin gene expression in transgenic mice: evidence for the importance of posttranscriptional regulation J Clin Invest 92 272 280 8325994 10.1172/JCI116561 1:CAS:528:DyaK3sXltlajsrk%3D Schnetzler B, Murakawa G, Abalos D, Halban P, Seiden R (1993) Adapatation to supraphysiologic levels of insulin gene expression in transgenic mice: evidence for the importance of posttranscriptional regulation. J Clin Invest 92: 272–280
26. 26. S Sizonenko PA Halban 1991 Differential rates of conversion of rat proinsulin I and II: evidence for slow cleavage at the B-chain/C-peptide junction of proinsulin II Biochem J 278 621 625 1898351 1:CAS:528:DyaK3MXlslGnsLg%3D Sizonenko S, Halban PA(1991) Differential rates of conversion of rat proinsulin I and II: evidence for slow cleavage at the B-chain/C-peptide junction of proinsulin II. Biochem J 278: 621–625
27. 27. PA Halban 1991 Structural domains and molecular lifestyles of insulin and its precursors in the pancreatic beta cell Diabetologia 34 767 778 1769434 10.1007/BF00408349 1:CAS:528:DyaK38Xht1Squr8%3D Halban PA(1991) Structural domains and molecular lifestyles of insulin and its precursors in the pancreatic beta cell. Diabetologia 34: 767–778
28. 28. SC Woods D Porte 1974 Neural control of the endocrine pancreas Physiol Rev 54 596 619 4601624 1:CAS:528:DyaE2cXltFOmsro%3D Woods SC, Porte D Jr (1974) Neural control of the endocrine pancreas. Physiol Rev 54: 596–619
29. 29. T Suda F Tozawa I Iwai 1993 Neuropeptide-Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus Mol Brain Res 18 311 315 8392133 10.1016/0169-328X(93)90094-6 1:CAS:528:DyaK3sXmtFygs70%3D Suda T, Tozawa F, Iwai I et al. (1993) Neuropeptide-Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. Mol Brain Res 18: 311–315
30. 30. DA Haas SR George 1987 Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity: lack of effect in other rat brain regions Life Sci 41 2725 2731 2826949 10.1016/0024-3205(87)90465-6 1:CAS:528:DyaL1cXhs1Gksg%3D%3D Haas DA, George SR (1987) Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity: lack of effect in other rat brain regions. Life Sci 41: 2725–2731
31. 31. AN Brooks DC Howe DWF Porter AM Naylor 1994 Neuropeptide-Y stimulates pituitary-adrenal activity in fetal and adult sheep J Neuroendocrinol 6 161 166 8049713 10.1111/j.1365-2826.1994.tb00567.x 1:CAS:528:DyaK2cXis1ahtr4%3D Brooks AN, Howe DC, Porter DWF, Naylor AM (1994) Neuropeptide-Y stimulates pituitary-adrenal activity in fetal and adult sheep. J Neuroendocrinol 6: 161–166
32. 32. JP Liu IJ Clarke JW Funder D Engler 1994 Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing’s syndrome of endogenous depression and anorexia nervosa J Clin Invest 93 1439 1450 8163648 10.1172/JCI117121 1:CAS:528:DyaK2cXis1Wkur8%3D Liu JP, Clarke IJ, Funder JW, Engler D (1994) Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing’s syndrome of endogenous depression and anorexia nervosa. J Clin Invest 93: 1439–1450
33. 33. MF Dallman AM Strack SF Akana 1993 Feast and famine: critical role of glucocorticoids with insulin in daily energy flow Front Neuroendocrinol 14 303 347 8258378 10.1006/frne.1993.1010 1:STN:280:DyaK2c%2FotV2gtA%3D%3D Dallman MF, Strack AM, Akana SF et al. (1993) Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Front Neuroendocrinol 14: 303–347
34. 34. M Miura A Inui A Teranishi 1992 Structural requirements for the effects of neuropeptide Y on the hypothalamic-pituitary-adrenal axis in the dog Neuropeptides 23 15 18 1328925 10.1016/0143-4179(92)90004-G 1:CAS:528:DyaK38XmsVGks7c%3D Miura M, Inui A, Teranishi A et al. (1992) Structural requirements for the effects of neuropeptide Y on the hypothalamic-pituitary-adrenal axis in the dog. Neuropeptides 23: 15–18
35. 35. C Gerald MW Walker L Criscione 1996 A receptor subtype involved in neuropeptide-Y-induced food intake Nature 382 168 171 8700207 10.1038/382168a0 1:CAS:528:DyaK28XktlSkur0%3D Gerald C, Walker MW, Criscione L et al. (1996) A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382: 168–171
36. 36. K Brück 1983 Functions of the endocrine system RF Schmidt G Thews Human Physiology Springer-Verlag Heidelberg 658 687 Brück K (1983) Functions of the endocrine system. In: Schmidt RF, Thews G (eds) Human Physiology. Springer-Verlag, Heidelberg, pp 658–687
37. 37. MF Dallman SF Akana KA Scribner 1992 Mortyn Jones memorial lecture. Stress, feedback and facilitation in the hypothalamo-pituitary adrenal axis J Neuroendocrinol 4 517 526 10.1111/j.1365-2826.1992.tb00200.x 1:CAS:528:DyaK38XmsVGltLk%3D Dallman MF, Akana SF, Scribner KA et al. (1992) Mortyn Jones memorial lecture. Stress, feedback and facilitation in the hypothalamo-pituitary adrenal axis. J Neuroendocrinol 4: 517–526
38. 38. KJ Kaiyala SC Woods MW Schwartz 1995 New model for the regulation of energy balance and adiposity by the central nervous system Am J Clin Nutr 62 1123S 1134S 7484931 1:STN:280:DyaK28%2Fjs1Gntw%3D%3D Kaiyala KJ, Woods SC, Schwartz MW (1995) New model for the regulation of energy balance and adiposity by the central nervous system. Am J Clin Nutr 62: 1123S-1134S
39. 39. JS Yudkin 1993 Circulating proinsulin-like molecules J Diabetic Complications 7 113 123 10.1016/1056-8727(93)90036-X 1:STN:280:DyaK3s3pvFSjug%3D%3D Yudkin JS (1993) Circulating proinsulin-like molecules. J Diabetic Complications 7: 113–123
40. 40. CJ Rhodes C Alarcon 1994 What beta-cell defect could lead to hyperproinsulinemia in NIDDM — some clues from recent advances made in understanding the proinsulin-processing mechanism Diabetes 43 511 517 8138054 10.2337/diabetes.43.4.511 1:CAS:528:DyaK2cXktVKit7s%3D Rhodes CJ, Alarcon C (1994) What beta-cell defect could lead to hyperproinsulinemia in NIDDM — some clues from recent advances made in understanding the proinsulin-processing mechanism. Diabetes 43: 511–517
41. 41. D Porte 1991 Banting lecture 1990. Beta cells in type II diabetes Diabetes 40 166 180 1991568 10.2337/diabetes.40.2.166 Porte D Jr (1991) Banting lecture 1990. Beta cells in type II diabetes. Diabetes 40: 166–180
42. 42. M Yoneda N Tamasawa K Takebe 1995 Central neuropeptide Y enhances bile secretion through vagal and muscarinic but not nitric oxide pathways in rats Peptides 16 727 732 7479309 10.1016/0196-9781(95)00041-H 1:CAS:528:DyaK2MXmtl2ku7c%3D Yoneda M, Tamasawa N, Takebe K et al. (1995) Central neuropeptide Y enhances bile secretion through vagal and muscarinic but not nitric oxide pathways in rats. Peptides 16: 727–732
43. 43. M Stubbs DA York 1991 Central glucocorticoid regulation of parasympathetic drive to pancreatic B-cells in the obese fa/fa rat Int J Obesity 15 547 553 1:CAS:528:DyaK3MXmslOjsbo%3D Stubbs M, York DA (1991) Central glucocorticoid regulation of parasympathetic drive to pancreatic B-cells in the obese fa/fa rat. Int J Obesity 15: 547–553
44. 44. JM Fletcher N McKenzie 1988 The parasympathetic nervous system and glucocorticoid-mediated hyperinsulinaemia in the genetically obese (fa/fa) Zucker rat J Endocrinol 118 87 92 3045246 10.1677/joe.0.1180087 1:CAS:528:DyaL1cXktlagsL0%3D Fletcher JM, McKenzie N (1988) The parasympathetic nervous system and glucocorticoid-mediated hyperinsulinaemia in the genetically obese (fa/fa) Zucker rat. J Endocrinol 118: 87–92
45. 45. P Siaud R Puech I Assenmacher G Alonso 1990 Adrenergic innervation of the dorsal vagal motor nucleus: possible involvement in inhibitory control of gastric acid and pancreatic insulin secretion Cell Tissue Res 259 535 542 2180575 10.1007/BF01740781 1:CAS:528:DyaK3cXhvFans7k%3D Siaud P, Puech R, Assenmacher I, Alonso G (1990) Adrenergic innervation of the dorsal vagal motor nucleus: possible involvement in inhibitory control of gastric acid and pancreatic insulin secretion. Cell Tissue Res 259: 535–542